Definium Therapeutics Inc. Common Shares vs YieldMax NVDA Option Income Strategy ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while YieldMax NVDA Option Income Strategy ETF trades at $12.79 (market cap $1.46B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 3.2× YieldMax NVDA Option Income Strategy ETF's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and YieldMax NVDA Option Income Strategy ETF for 43 Days on average.
| DFTX | NVDY | |
|---|---|---|
Market Cap | $4.71B | $1.46B |
Volume | 1,966,636 | 1,111,033 |
Sector | Health | Income / Options Overlay |
52-Week High | $48.45 | $17.21 |
52-Week Low | $10.68 | $11.58 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $3.67B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVDY trades at $13.01, down 0.31% on the day, with a bullish technical signal from moving averages but neutral oscillators. The ETF generates weekly dividends, averaging around $0.10 per share recently, reflecting its income-focused strategy tied to NVIDIA's stock volatility. However, key valuation ratios like P/E and P/S are unavailable, limiting fundamental clarity.
The outlook is mixed: strong dividend yields appeal to income seekers, but structural caps on upside participation and potential NAV erosion pose long-term risks. Analyst sentiment has shifted to hold due to declining volatility in NVIDIA, suggesting cautious optimism for income but limited growth potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →